Vitamins and Non-alcoholic Fatty Liver Disease: A Molecular Insight

Overview

Journal Liver Res

Date 2021 Jul 5

PMID 34221537

Citations 22

Authors

Sana Raza

Archana Tewari

Sangam Rajak

Rohit A Sinha

Affiliations

Soon will be listed here.

Abstract

The incidence of non-alcoholic fatty liver disease (NAFLD) is rising rapidly across the globe. NAFLD pathogenesis is largely driven by an imbalance in hepatic energy metabolism and at present, there is no approved drug for its treatment. The liver plays a crucial role in micronutrient metabolism and deregulation of this micronutrient metabolism may contribute to the pathogenesis of NAFLD. Vitamins regulate several enzymatic processes in the liver, and derangement in vitamin metabolism is believed to play a critical role in NAFLD progression. The anti-oxidant activities of vitamin C and E have been attributed to mitigate hepatocyte injury, and alterations in the serum levels of vitamin D, vitamin B12 and folate have shown a strong correlation with NAFLD severity. This review aims to highlight the role of these vitamins, which represent promising therapeutic targets for the management of NAFLD.

Citing Articles

Multivitamin supplementation and its impact in metabolic dysfunction-associated steatotic liver disease.

Ryu T, Chae S, Lee J, Han J, Yang H, Chung B Sci Rep. 2025; 15(1):8675.

PMID: 40082562 PMC: 11906897. DOI: 10.1038/s41598-025-92858-0.

Prophylactic effects of nutrition, dietary strategies, exercise, lifestyle and environment on nonalcoholic fatty liver disease.

Hao X, Song H, Su X, Li J, Ye Y, Wang C Ann Med. 2025; 57(1):2464223.

PMID: 39943720 PMC: 11827040. DOI: 10.1080/07853890.2025.2464223.

Detection of reproducible liver cancer specific ligand-receptor signaling in blood.

Safrastyan A, Wollny D Front Bioinform. 2025; 4():1332782.

PMID: 39850635 PMC: 11754192. DOI: 10.3389/fbinf.2024.1332782.

Associations of serum folate and vitamin B levels with all-cause mortality among patients with metabolic dysfunction associated steatotic liver disease: a prospective cohort study.

Zhu J, Liao X, Du L, Lv P, Deng J Front Endocrinol (Lausanne). 2024; 15:1426103.

PMID: 39703860 PMC: 11655224. DOI: 10.3389/fendo.2024.1426103.

U-shaped association of serum vitamin A concentrations with all-cause mortality in patients with NAFLD: results from the NHANES database prospective cohort study.

Li H, Ye J, Dong Y, Kong W, Qian G, Xie Y Front Nutr. 2024; 11:1467659.

PMID: 39539372 PMC: 11558463. DOI: 10.3389/fnut.2024.1467659.

References

Heemskerk M, van den Berg S, Pronk A, van Klinken J, Boon M, Havekes L . Long-term niacin treatment induces insulin resistance and adrenergic responsiveness in adipocytes by adaptive downregulation of phosphodiesterase 3B. Am J Physiol Endocrinol Metab. 2014; 306(7):E808-13. PMC: 3962609. DOI: 10.1152/ajpendo.00641.2013. View

Han S, Chiang J . Mechanism of vitamin D receptor inhibition of cholesterol 7alpha-hydroxylase gene transcription in human hepatocytes. Drug Metab Dispos. 2008; 37(3):469-78. PMC: 2680517. DOI: 10.1124/dmd.108.025155. View

Li J, Cordero P, Nguyen V, Oben J . The Role of Vitamins in the Pathogenesis of Non-alcoholic Fatty Liver Disease. Integr Med Insights. 2016; 11:19-25. PMC: 4849418. DOI: 10.4137/IMI.S31451. View

Fabbrini E, Mohammed B, Korenblat K, Magkos F, McCrea J, Patterson B . Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2010; 95(6):2727-35. PMC: 2902076. DOI: 10.1210/jc.2009-2622. View

Lalloyer F, Pedersen T, Gross B, Lestavel S, Yous S, Vallez E . Rexinoid bexarotene modulates triglyceride but not cholesterol metabolism via gene-specific permissivity of the RXR/LXR heterodimer in the liver. Arterioscler Thromb Vasc Biol. 2009; 29(10):1488-95. PMC: 2824837. DOI: 10.1161/ATVBAHA.109.189506. View

Pettinelli P, Arendt B, Teterina A, McGilvray I, Comelli E, Fung S . Altered hepatic genes related to retinol metabolism and plasma retinol in patients with non-alcoholic fatty liver disease. PLoS One. 2018; 13(10):e0205747. PMC: 6209208. DOI: 10.1371/journal.pone.0205747. View

Charlton M, Burns J, Pedersen R, Watt K, Heimbach J, Dierkhising R . Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011; 141(4):1249-53. DOI: 10.1053/j.gastro.2011.06.061. View

Madan K, Bhardwaj P, Thareja S, Gupta S, Saraya A . Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). J Clin Gastroenterol. 2006; 40(10):930-5. DOI: 10.1097/01.mcg.0000212608.59090.08. View

Younossi Z, Stepanova M, Ong J, Jacobson I, Bugianesi E, Duseja A . Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates. Clin Gastroenterol Hepatol. 2018; 17(4):748-755.e3. DOI: 10.1016/j.cgh.2018.05.057. View

10.

Ahmad S, Kumar K, Basak T, Bhardwaj G, Yadav D, Lalitha A . PPAR signaling pathway is a key modulator of liver proteome in pups born to vitamin B(12) deficient rats. J Proteomics. 2013; 91:297-308. DOI: 10.1016/j.jprot.2013.07.027. View

11.

Debbabi M, Nury T, Zarrouk A, Mekahli N, Bezine M, Sghaier R . Protective Effects of α-Tocopherol, γ-Tocopherol and Oleic Acid, Three Compounds of Olive Oils, and No Effect of Trolox, on 7-Ketocholesterol-Induced Mitochondrial and Peroxisomal Dysfunction in Microglial BV-2 Cells. Int J Mol Sci. 2016; 17(12). PMC: 5187773. DOI: 10.3390/ijms17121973. View

12.

Kjalarsdottir L, Tersey S, Vishwanath M, Chuang J, Posner B, Mirmira R . 1,25-Dihydroxyvitamin D enhances glucose-stimulated insulin secretion in mouse and human islets: a role for transcriptional regulation of voltage-gated calcium channels by the vitamin D receptor. J Steroid Biochem Mol Biol. 2018; 185:17-26. DOI: 10.1016/j.jsbmb.2018.07.004. View

13.

Levine B, Packer M, Codogno P . Development of autophagy inducers in clinical medicine. J Clin Invest. 2015; 125(1):14-24. PMC: 4382267. DOI: 10.1172/JCI73938. View

14.

Liu Y, Chen H, Wang J, Zhou W, Sun R, Xia M . Association of serum retinoic acid with hepatic steatosis and liver injury in nonalcoholic fatty liver disease. Am J Clin Nutr. 2015; 102(1):130-7. DOI: 10.3945/ajcn.114.105155. View

15.

Schreuder T, Verwer B, van Nieuwkerk C, Mulder C . Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment. World J Gastroenterol. 2008; 14(16):2474-86. PMC: 2708357. DOI: 10.3748/wjg.14.2474. View

16.

Faeh D, Chiolero A, Paccaud F . Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about?. Swiss Med Wkly. 2007; 136(47-48):745-56. DOI: 10.4414/smw.2006.11283. View

17.

Hu M, Chu W, Yamashita S, Yeung D, Shi L, Wang D . Liver fat reduction with niacin is influenced by DGAT-2 polymorphisms in hypertriglyceridemic patients. J Lipid Res. 2012; 53(4):802-9. PMC: 3307657. DOI: 10.1194/jlr.P023614. View

18.

Sid V, Wu N, Sarna L, Siow Y, House J, O K . Folic acid supplementation during high-fat diet feeding restores AMPK activation via an AMP-LKB1-dependent mechanism. Am J Physiol Regul Integr Comp Physiol. 2015; 309(10):R1215-25. PMC: 4666937. DOI: 10.1152/ajpregu.00260.2015. View

19.

Elseweidy M, Amin R, Atteia H, Ali M . Vitamin D3 intake as regulator of insulin degrading enzyme and insulin receptor phosphorylation in diabetic rats. Biomed Pharmacother. 2016; 85:155-159. DOI: 10.1016/j.biopha.2016.11.116. View

20.

Dong B, Zhou Y, Wang W, Scott J, Kim K, Sun Z . Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice. Hepatology. 2019; 71(5):1559-1574. DOI: 10.1002/hep.30937. View